Onyx Healthcare Inc. (TPEX:6569)
Taiwan
· Delayed Price · Currency is TWD 121.00
-2.00 (-1.63%)
Apr 24, 2025, 1:30 PM CST
Onyx Healthcare Income Statement
Financials in millions TWD. Fiscal year is January - December.
Millions TWD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Revenue | 1,241 | 1,493 | 1,600 | 1,202 | 1,347 | Upgrade
|
| Revenue Growth (YoY) | -16.85% | -6.71% | 33.16% | -10.80% | -9.15% | Upgrade
|
| Cost of Revenue | 784.98 | 936.72 | 1,128 | 838.03 | 883.3 | Upgrade
|
| Gross Profit | 456.28 | 556.14 | 472.31 | 363.73 | 464.01 | Upgrade
|
| Selling, General & Admin | 247.47 | 258.98 | 241.59 | 208.96 | 232.16 | Upgrade
|
| Research & Development | 118.32 | 79.36 | 86.67 | 79.35 | 68.64 | Upgrade
|
| Operating Expenses | 367.55 | 338.02 | 326.91 | 289.22 | 303.35 | Upgrade
|
| Operating Income | 88.73 | 218.12 | 145.39 | 74.51 | 160.66 | Upgrade
|
| Interest Expense | -4.36 | -3.68 | -3.56 | -2.63 | -0.48 | Upgrade
|
| Interest & Investment Income | 13.88 | 3.39 | 4.69 | 6.36 | 2.29 | Upgrade
|
| Earnings From Equity Investments | 67.1 | 62.87 | 62.94 | 50.19 | 33.9 | Upgrade
|
| Currency Exchange Gain (Loss) | 13.12 | -7.42 | 19.28 | -6.02 | -12.29 | Upgrade
|
| Other Non Operating Income (Expenses) | 18 | 19.85 | 25.41 | 18.57 | 14.67 | Upgrade
|
| EBT Excluding Unusual Items | 196.47 | 293.14 | 254.14 | 140.98 | 198.76 | Upgrade
|
| Gain (Loss) on Sale of Investments | 9.95 | 11.86 | -12.45 | -0.87 | 3.86 | Upgrade
|
| Gain (Loss) on Sale of Assets | - | - | 0.25 | - | - | Upgrade
|
| Other Unusual Items | -0.01 | 0.01 | 0.09 | -0.01 | - | Upgrade
|
| Pretax Income | 206.41 | 305 | 242.03 | 140.11 | 202.61 | Upgrade
|
| Income Tax Expense | 26.28 | 49.83 | 38.9 | 13.6 | 37.71 | Upgrade
|
| Earnings From Continuing Operations | 180.13 | 255.17 | 203.14 | 126.51 | 164.91 | Upgrade
|
| Minority Interest in Earnings | 0.79 | 0.09 | -0.18 | 1.04 | 2.17 | Upgrade
|
| Net Income | 180.91 | 255.26 | 202.96 | 127.55 | 167.08 | Upgrade
|
| Net Income to Common | 180.91 | 255.26 | 202.96 | 127.55 | 167.08 | Upgrade
|
| Net Income Growth | -29.13% | 25.77% | 59.12% | -23.66% | -30.20% | Upgrade
|
| Shares Outstanding (Basic) | 39 | 38 | 37 | 35 | 35 | Upgrade
|
| Shares Outstanding (Diluted) | 39 | 39 | 38 | 35 | 35 | Upgrade
|
| Shares Change (YoY) | 0.61% | 2.85% | 7.68% | -0.14% | 0.11% | Upgrade
|
| EPS (Basic) | 4.69 | 6.66 | 5.43 | 3.67 | 4.80 | Upgrade
|
| EPS (Diluted) | 4.65 | 6.60 | 5.39 | 3.65 | 4.77 | Upgrade
|
| EPS Growth | -29.54% | 22.41% | 47.62% | -23.50% | -30.27% | Upgrade
|
| Free Cash Flow | 117.53 | 282.91 | 149.84 | -277.64 | 179.82 | Upgrade
|
| Free Cash Flow Per Share | 3.02 | 7.31 | 3.98 | -7.95 | 5.14 | Upgrade
|
| Dividend Per Share | 4.000 | 4.348 | 4.348 | 3.479 | 4.348 | Upgrade
|
| Dividend Growth | -8.01% | - | 25.00% | -20.00% | 14.58% | Upgrade
|
| Gross Margin | 36.76% | 37.25% | 29.51% | 30.27% | 34.44% | Upgrade
|
| Operating Margin | 7.15% | 14.61% | 9.09% | 6.20% | 11.92% | Upgrade
|
| Profit Margin | 14.57% | 17.10% | 12.68% | 10.61% | 12.40% | Upgrade
|
| Free Cash Flow Margin | 9.47% | 18.95% | 9.36% | -23.10% | 13.35% | Upgrade
|
| EBITDA | 105.12 | 235.93 | 163.63 | 90.84 | 174.4 | Upgrade
|
| EBITDA Margin | 8.47% | 15.80% | 10.22% | 7.56% | 12.94% | Upgrade
|
| D&A For EBITDA | 16.4 | 17.81 | 18.24 | 16.33 | 13.74 | Upgrade
|
| EBIT | 88.73 | 218.12 | 145.39 | 74.51 | 160.66 | Upgrade
|
| EBIT Margin | 7.15% | 14.61% | 9.09% | 6.20% | 11.92% | Upgrade
|
| Effective Tax Rate | 12.73% | 16.34% | 16.07% | 9.71% | 18.61% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.